{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:34:43Z","timestamp":1776162883110,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-016-2998-2","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T23:51:51Z","timestamp":1483746711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis"],"prefix":"10.1186","volume":"17","author":[{"given":"Heather L.","family":"Stevenson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana M.","family":"Prats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5925-422X","authenticated-orcid":false,"given":"Eizaburo","family":"Sasatomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,7]]},"reference":[{"key":"2998_CR1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/bega.2002.0286","volume":"16","author":"PM Schlag","year":"2002","unstructured":"Schlag PM, Benhidjeb T, Stroszczynski C. Resection and local therapy for liver metastases. Best Pract Res Clin Gastroenterol. 2002;16:299\u2013317.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2998_CR2","first-page":"266","volume":"26","author":"DL Bartlett","year":"2012","unstructured":"Bartlett DL, Chu E. Can metastatic colorectal cancer be cured? Oncology (Williston Park). 2012;26:266\u201375.","journal-title":"Oncology (Williston Park)"},{"key":"2998_CR3","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/annonc\/mdu088","volume":"25","author":"G Folprecht","year":"2014","unstructured":"Folprecht G, Gruenberger T, Bechstein W, Raab HR, Weitz J, Lordick F, Hartmann JT, Stoehlmacher-Williams J, Lang H, Trarbach T, Liersch T, Ockert D, Jaeger D, Steger U, Suedhoff T, Rentsch A, K\u00f6hne CH. Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX\/cetuximab or FOLFIRI\/cetuximab in a multidisciplinary concept (CELIM study). Ann Oncol. 2014;25:1018\u201325.","journal-title":"Ann Oncol"},{"key":"2998_CR4","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.critrevonc.2013.05.011","volume":"88","author":"D McWhirter","year":"2013","unstructured":"McWhirter D, Kitteringham N, Jones RP, Malik H, Park K, Palmer D. Chemotherapy induced hepatotoxicity in metastatic colorectal cancer: a review of mechanisms and outcomes. Crit Rev Oncol Hematol. 2013;88:404\u201315.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2998_CR5","doi-asserted-by":"crossref","unstructured":"Nguyen-Khac E, Lobry C, Chatelain D, Fuks D, Joly JP, Brevet M, Tramier B, Mouly C, Hautefeuille V, Chauffert B, Regimbeau JM. A reappraisal of chemotherapy-induced liver injury in colorectal liver metastases before the era of antiangiogenics. Int J Hepatol. 2013;2013(314868):11.","DOI":"10.1155\/2013\/314868"},{"key":"2998_CR6","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1245\/s10434-012-2438-8","volume":"19","author":"SM Robinson","year":"2012","unstructured":"Robinson SM, Wilson CH, Burt AD, Manas DM, White SA. Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann Surg Oncol. 2012;19:4287\u201399.","journal-title":"Ann Surg Oncol"},{"key":"2998_CR7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1245\/s10434-010-1201-2","volume":"18","author":"PJ Kneuertz","year":"2011","unstructured":"Kneuertz PJ, Maithel SK, Staley CA, Kooby DA. Chemotherapy-associated liver injury: impact on surgical management of colorectal cancer liver metastases. Ann Surg Oncol. 2011;18:181\u201390.","journal-title":"Ann Surg Oncol"},{"key":"2998_CR8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jceh.2014.10.002","volume":"4","author":"CQ Fan","year":"2014","unstructured":"Fan CQ, Crawford JM. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp Hepatol. 2014;4:332\u201346.","journal-title":"J Clin Exp Hepatol"},{"key":"2998_CR9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2559.2010.03511.x","volume":"56","author":"L Rubbia-Brandt","year":"2010","unstructured":"Rubbia-Brandt L, Lauwers GY, Wang H, Majno PE, Tanabe K, Zhu AX, Brezault C, Soubrane O, Abdalla EK, Vauthey JN, Mentha G, Terris B. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology. 2010;56:430\u20139.","journal-title":"Histopathology"},{"key":"2998_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/hepr.12107","volume":"44","author":"Y Morine","year":"2014","unstructured":"Morine Y, Shimada M, Utsunomiya T. Evaluation and management of hepatic injury induced by oxaliplatin-based chemotherapy in patients with hepatic resection for colorectal liver metastasis. Hepatol Res. 2014;44:59\u201369.","journal-title":"Hepatol Res"},{"key":"2998_CR11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2559.2012.04208.x","volume":"61","author":"CP Vreuls","year":"2012","unstructured":"Vreuls CP, Van Den Broek MA, Winstanley A, Koek GH, Wisse E, Dejong CH, Olde Damink SW, Bosman FT, Driessen A. Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases. Histopathology. 2012;61:314\u20138.","journal-title":"Histopathology"},{"key":"2998_CR12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/SLA.0b013e3182a6183e","volume":"258","author":"L Vigan\u00f2","year":"2013","unstructured":"Vigan\u00f2 L, Capussotti L, De Rosa G, De Saussure WO, Mentha G, Rubbia-Brandt L. Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival. Ann Surg. 2013;258:731\u201340.","journal-title":"Ann Surg"},{"key":"2998_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00595-010-4414-x","volume":"41","author":"M Narita","year":"2011","unstructured":"Narita M, Oussoultzoglou E, Chenard MP, Rosso E, Casnedi S, Pessaux P, Bachellier P, Jaeck D. Sinusoidal obstruction syndrome compromises liver regeneration in patients undergoing two-stage hepatectomy with portal vein embolization. Surg Today. 2011;41:7\u201317.","journal-title":"Surg Today"},{"key":"2998_CR14","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1245\/s10434-011-2112-6","volume":"19","author":"M Narita","year":"2012","unstructured":"Narita M, Oussoultzoglou E, Chenard MP, Fuchshuber P, Rather M, Rosso E, Addeo P, Jaeck D, Bachellier P. Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization. Ann Surg Oncol. 2012;19:2230\u20137.","journal-title":"Ann Surg Oncol"},{"key":"2998_CR15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/1751-2980.12177","volume":"15","author":"IL Nalbantoglu","year":"2014","unstructured":"Nalbantoglu IL, Tan Jr BR, Linehan DC, Gao F, Brunt EM. Histological features and severity of oxaliplatin-induced liver injury and clinical associations. J Dig Dis. 2014;15:553\u201360.","journal-title":"J Dig Dis"},{"key":"2998_CR16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1096\/fasebj.5.3.2001786","volume":"5","author":"R Blomhoff","year":"1991","unstructured":"Blomhoff R, Wake K. Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis. FASEB J. 1991;5:271\u20137.","journal-title":"FASEB J"},{"key":"2998_CR17","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3346\/jkms.2013.28.12.1835","volume":"28","author":"GH Kang","year":"2013","unstructured":"Kang GH, Moon HS, Lee ES, Kim SH, Sung JK, Lee BS, Jeong HY, Lee HY, Kang DY. A case of liver fibrosis with splenomegaly after oxaliplatin-based adjuvant chemotherapy for colon cancer. J Korean Med Sci. 2013;28:1835\u20138.","journal-title":"J Korean Med Sci"},{"key":"2998_CR18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","volume":"15","author":"L Rubbia-Brandt","year":"2004","unstructured":"Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane O, Chaussade S, Mentha G, Terris B. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol. 2004;15:460\u20136.","journal-title":"Ann Oncol"},{"key":"2998_CR19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1478-3231.2008.01849.x","volume":"29","author":"P Bioulac-Sage","year":"2009","unstructured":"Bioulac-Sage P, Laumonier H, Rullier A, Cubel G, Laurent C, Zucman-Rossi J, Balabaud C. Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int. 2009;29:459\u201365.","journal-title":"Liver Int"},{"key":"2998_CR20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/modpathol.2013.114","volume":"27","author":"NM Joseph","year":"2014","unstructured":"Joseph NM, Ferrell LD, Jain D, Torbenson MS, Wu TT, Yeh MM, Kakar S. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma. Mod Pathol. 2014;27:62\u201372.","journal-title":"Mod Pathol"},{"key":"2998_CR21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/liv.12099","volume":"33","author":"KE Fleming","year":"2013","unstructured":"Fleming KE, Wanless IR. Glutamine synthetase expression in activated hepatocyte progenitor cells and loss of hepatocellular expression in congestion and cirrhosis. Liver Int. 2013;33:525\u201334.","journal-title":"Liver Int"},{"key":"2998_CR22","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/hepr.12506","volume":"45","author":"Y Sato","year":"2015","unstructured":"Sato Y, Harada K, Sasaki M, Nakanuma Y. Altered intrahepatic microcirculation of idiopathic portal hypertension in relation to glutamine synthetase expression. Hepatol Res. 2015;45:1323\u201330.","journal-title":"Hepatol Res"},{"key":"2998_CR23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1185\/03007995.2010.536912","volume":"27","author":"X Song","year":"2011","unstructured":"Song X, Zhao Z, Barber B, Gregory C, Wang PF, Long SR. Treatment patterns and metastasectomy among mCRC patients receiving chemotherapy and biologics. Curr Med Res Opin. 2011;27:123\u201330.","journal-title":"Curr Med Res Opin"},{"key":"2998_CR24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1200\/JOP.2010.000072","volume":"6","author":"GP Hess","year":"2010","unstructured":"Hess GP, Wang PF, Quach D, Barber B, Zhao Z. Systemic therapy for metastatic colorectal cancer: patterns of chemotherapy and biologic therapy use in US medical oncology practice. J Oncol Pract. 2010;6:301\u20137.","journal-title":"J Oncol Pract"},{"key":"2998_CR25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1477-2574.2012.00558.x","volume":"15","author":"RE Schwarz","year":"2013","unstructured":"Schwarz RE, Berlin JD, Lenz HJ, Nordlinger B, Rubbia-Brandt L, Choti MA. Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement. HPB (Oxford). 2013;15:106\u201315.","journal-title":"HPB (Oxford)"},{"key":"2998_CR26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","volume":"247","author":"H Nakano","year":"2008","unstructured":"Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P, Bachellier P, Jaeck D. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg. 2008;247:118\u201324.","journal-title":"Ann Surg"},{"key":"2998_CR27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1245\/s10434-010-1317-4","volume":"18","author":"D Tamandl","year":"2011","unstructured":"Tamandl D, Klinger M, Eipeldauer S, Herberger B, Kaczirek K, Gruenberger B, Gruenberger T. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy. Ann Surg Oncol. 2011;18:421\u201330.","journal-title":"Ann Surg Oncol"},{"key":"2998_CR28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","volume":"22","author":"LD DeLeve","year":"2002","unstructured":"DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis. 2002;22:27\u201342.","journal-title":"Semin Liver Dis"},{"key":"2998_CR29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1369\/jhc.4A6514.2005","volume":"54","author":"MP Pusztaszeri","year":"2006","unstructured":"Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem. 2006;54:385\u201395.","journal-title":"J Histochem Cytochem"},{"key":"2998_CR30","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/hep.27376","volume":"61","author":"LD DeLeve","year":"2015","unstructured":"DeLeve LD. Liver sinusoidal endothelial cells in hepatic fibrosis. Hepatology. 2015;61:1740\u20136.","journal-title":"Hepatology"},{"key":"2998_CR31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1365-2559.1999.00569.x","volume":"34","author":"Y Sato","year":"1999","unstructured":"Sato Y, Asada Y, Hara S, Marutsuka K, Tamura K, Hayashi T, Sumiyoshi A. Hepatic stellate cells (Ito cells) in veno-occlusive disease of the liver after allogeneic bone marrow transplantation. Histopathology. 1999;34:66\u201370.","journal-title":"Histopathology"},{"key":"2998_CR32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.proghi.2006.12.001","volume":"41","author":"R Gebhardt","year":"2007","unstructured":"Gebhardt R, Baldysiak-Figiel A, Kr\u00fcgel V, Ueberham E, Gaunitz F. Hepatocellular expression of glutamine synthetase: an indicator of morphogen actions as master regulators of zonation in adult liver. Prog Histochem Cytochem. 2007;41:201\u201366.","journal-title":"Prog Histochem Cytochem"},{"key":"2998_CR33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/978-1-4419-7107-4_2","volume-title":"Molecular pathology of liver diseases","author":"S Colnot","year":"2011","unstructured":"Colnot S, Perret C. Liver zonation. In: Monga SPS, editor. Molecular pathology of liver diseases. New York: Springer; 2011. p. 7\u201329."},{"key":"2998_CR34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/bjh.12558","volume":"163","author":"FL Dignan","year":"2013","unstructured":"Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A, Veys P, Potter MN, Haemato-oncology Task Force of British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation. BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol. 2013;163:444\u201357.","journal-title":"Br J Haematol"},{"key":"2998_CR35","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1200\/JCO.2009.27.5701","volume":"28","author":"MJ Overman","year":"2010","unstructured":"Overman MJ, Maru DM, Charnsangavej C, Loyer EM, Wang H, Pathak P, Eng C, Hoff PM, Vauthey JN, Wolff RA, Kopetz S. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol. 2010;28:2549\u201355.","journal-title":"J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2998-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T03:29:09Z","timestamp":1568690949000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2998-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2998"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2998-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,7]]},"article-number":"35"}}